The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer
The purpose of this study is to find out the effect of Dexmedetomidine for treatment of sleep deprivation, pain relief and postoperative recovery on middle-aged and elderly Patients with Gastric Cancer.
Gastric Cancer
DRUG: dexmedetomidine
sleep time, total sleep time during the first three days after surgery, during the first three days after surgery
pain score, pain score measure, during the first three days after surgery|daily sufentanil consumption, daily sufentanil consumption, during the first three days after surgery|functional recovery, time to functional recovery, during the first three days after surgery|length of hospital stay, length of hospital stay, during the first three days after surgery|side effects, lethargy and mental sluggishness, during the first three days after surgery
Patients were randomized to receive sufentanil 0.05ug/kh/h + dexmedetomidine 0.1ug/kg/h (DEX group) or sufentanil 0.05ug/kg/h + saline (control group) for 48h. The primary outcome was the total sleep time during the first three days after surgery. The secondary outcomes included pain score, daily sufentanil consumption, time to functional recovery, length of hospital stay and side effects.